Aug 12, 2021 — 3 min read
Fujifilm, a leader in diagnostic imaging products and medical information solutions, to provide AI-powered chest X-ray software ‘CXR-AID’ in Japan with PMDA approval
Developed with core AI technology from Lunit, a partner of Fujifilm since 2018
Fujifilm Corporation, a global medical imaging device provider, today announced its AI-powered product for analyzing chest X-ray ‘CXR-AID’ will be commercially available across Japan.
CXR-AID is designed to better detect major abnormal findings such as chest nodule, consolidation, and pneumothorax from chest X-ray images. Findings detected by the AI software are shown in color as a heatmap display, with each score included. Through this solution, doctors and medical professionals are able to reduce missed cases and effectively diagnose chest diseases from chest X-ray.
The PMDA approved AI-powered software is developed with the core AI technology of Lunit, the company’s solid partner since 2018. The software is provided with Fujifilm’s PACS system(SYNAPSE) and to be distributed across hospitals and medical institutions of Japan for more efficient diagnosis. A leading medical AI company, Lunit provides deep-learning based AI technology called ‘Lunit INSIGHT CXR’ that analyzes chest X-rays.
<Lunit and Fujifilm Collaboration>
With Lunit AI connected to Fujifilm’s PACS system and X-ray devices, the AI products are distributed across its global customers and networks. The company has also invested in Lunit as a strategic investor.
“As a software company, collaborating with global medical device companies like Fujifilm is one of the key strategies for us to achieve successful market expansion,” said Brandon Suh, CEO of Lunit. “Fujifilm is one of our very first global partners, where we started our journey together in RSNA 2018. Thanks to this long trusted partnership, we were able to expand worldwide for the past 2.5 years to support medical professionals. Now we are very delighted to be introduced in hospitals and medical institutions of Japan.”
“We try to listen to our customers’ voice and Lunit’s AI software is gaining very positive feedback from the actual users across the world,” said Naoya Yamakawa, Senior Manager, IT solutions division of Medical Systems Business Division, Fujifilm Corporation. “For example, one of our customers Salud Digna, known as the largest medical institution of Mexico, uses our AI-embedded PACS to analyze more than 800,000 X-ray images per year. From the initial installation stage, the radiologists showed satisfaction for its accurate detection, and retention rate is growing higher.”
Based on this market needs, the two companies are expanding their scope of collaboration. Lunit AI is also applied in Fujifilm’s mobile X-ray device (FDR nano) and portable X-ray devices (FDR Xair), General X-ray device (FDR Smart X), and is in use in clinical settings to detect COVID-19 symptoms and tuberculosis in regions where there are a limited number of doctors. The products are installed worldwide including the UK, Thailand, Vietnam, Turkey, Middle East and Africa. Recently, Lunit’s AI solution for breast cancer detection, Lunit INSIGHT MMG, has been implemented in NURA, Fujifilm’s AI-based healthcare center in India.
“We strongly believe that sooner or later AI will become the new standard of care, and AI will be used everywhere as a must-use product,” added Suh. “Not only will it be used as a tool to make the workflow more efficient, but it will ensure better diagnosis and healthier life for patients. We are glad to make this happen with Fujifilm, and will accelerate our expansion with its global network.”
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Cognitive biases and augmented intelligence in radiology
Uncertainty and Deep Learning
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
Lunit preps Korean IPO led by NH Investment Bank
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit announces new members in its advisory board: Dr. Eliot Siegel, Dr. Linda Moy, and Dr. Khan Siddiqui
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Renowned Oncologist Dr. Tony Mok Joins Lunit Advisory Board
Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries
Lunit Awarded as Technology Pioneer by World Economic Forum
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
What do medical studies say about AI for COVID-19 management?
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
Lunit Secures $26M Investment from Guardant Health in a Strategic Funding Round
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021
Case of the Month (Chest x-ray)
COVID Global User Testimonials
Where is Cancer?
Breast Cancer Awareness Month — Ambassador Messages
TimeSformer: Is Space-Time Attention All You Need for Video Understanding?
Evaluation curves for object detection algorithms in medical images
Lunit to Participate in RSNA 2021, Presenting its New AI Solutions for Digital Breast Tomosynthesis and Chest CT
RadLink, Singapore’s Leading Imaging Center, Adapts Lunit AI to Analyze Chest X-rays and Mammograms
Lunit Expands Team with Multiple Industry Leaders to Accelerate its Business Growth
Lunit Presents Studies at SITC 2021, Highlighting the Effectiveness of AI in Predicting Response to Immunotherapy in a Clinical Trial Setting
Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
Research Backs Clinical Efficacy of Lunit's Radiology AI Products; Abstracts to be Presented at RSNA 2021
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries
Lunit to Showcase Chest and Breast Radiology AI in Arab Health 2022
Baheya Foundation, Egypt’s Premier Destination for Breast Cancer, Adopts Lunit AI to Enhance Early Screening
Lunit AI Demonstrates Accuracy in Practical Assessment of Cancer Tissue-Findings to Be Presented at USCAP 2022
Case of the Month (Chest x-ray) - Tuberculosis Case
Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ
Lunit AI solution for PD-L1 expression analysis receives CE mark
Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy as Diagnostic Aid in Cancer Treatment–Published in the European Journal of Cancer
Lunit Files Registration Statement for Initial Public Offering
Lunit AI Solution for Radiology Receives Health Canada Nod for Commercial Use